Publication | Closed Access

Development of a PIV-vectored RSV vaccine: Preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults

VaccinationVaccine SafetyPiv-vectored Rsv VaccineVaccine DevelopmentVaccine ResearchVaccine TargetVaccine TestingVirologyMedicinePreclinical EvaluationInitial Clinical Testing